Last Updated: November 9, 2026

Suppliers and packagers for CHABELINA FE

« Back to Dashboard


CHABELINA FE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novast Labs CHABELINA FE ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 202962 ANDA Mayne Pharma Inc. 51862-896-01 1 BLISTER PACK in 1 PACKET (51862-896-01) / 1 KIT in 1 BLISTER PACK 2020-10-15
Novast Labs CHABELINA FE ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 202962 ANDA Mayne Pharma Inc. 51862-896-02 1 BLISTER PACK in 1 CARTON (51862-896-02) / 1 KIT in 1 BLISTER PACK 2020-10-15
Novast Labs CHABELINA FE ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 202962 ANDA Mayne Pharma Inc. 51862-896-06 6 BLISTER PACK in 1 CARTON (51862-896-06) / 1 KIT in 1 BLISTER PACK 2020-10-15
Novast Labs CHABELINA FE ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 202962 ANDA Dr. Reddy?s Laboratories Inc. 75907-086-28 1 BLISTER PACK in 1 PACKET (75907-086-28) / 1 KIT in 1 BLISTER PACK 2024-06-01
Novast Labs CHABELINA FE ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 202962 ANDA Dr. Reddy?s Laboratories Inc. 75907-086-32 3 BLISTER PACK in 1 CARTON (75907-086-32) / 1 KIT in 1 BLISTER PACK 2024-06-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for CHABELINA FE

Last updated: June 12, 2026

CHABELINA FE (iron + folic acid) suppliers: who sells the finished drug and key raw materials?

Executive summary: No authoritative, product-specific supplier list can be produced for “CHABELINA FE” from the information provided. The name may refer to a branded oral iron/folate medicine, but supplier identification requires verified linkage to a specific country listing, manufacturer, or NDA/marketing authorization. Without that linkage, any supplier roster would be speculative.

H1 data gap: Supplier identification depends on confirming at least one of: (1) the marketing authorization holder/manufacturer name on the packaging or registration, (2) the FDA/NDA/ANDA label or Orange Book listing (if in the US), (3) a country-specific drug registry entry for “CHABELINA FE,” or (4) a legally enforceable procurement specification that maps the brand to an active pharmaceutical ingredient (API) and manufacturer.

What suppliers make CHABELINA FE finished tablets or capsules?

Answer: Not determinable from the prompt. “CHABELINA FE” is a brand-style label and may correspond to multiple formulations (different iron salts, strengths, and excipients) across jurisdictions. Finished-dose sourcing varies by country and by whether the distributor is the manufacturer or a wholesaler.

Which manufacturers are the marketing authorization holders?

Not determinable.

Which distributors/wholesalers supply it to pharmacies?

Not determinable.

What raw material suppliers provide the iron and folic acid used in CHABELINA FE?

Answer: Not determinable from the prompt. “FE” indicates iron, but the specific iron salt (eg, ferrous sulfate, fumarate, gluconate) and folic acid form affect approved supplier qualification and procurement specs.

Which iron salt suppliers are commonly used for FE brands?

Not determinable for CHABELINA FE specifically.

Which folic acid suppliers are used for iron + folate products?

Not determinable for CHABELINA FE specifically.

How do iron salt choice and bioequivalence requirements change supplier selection?

Answer: Not determinable. Supplier acceptance depends on regulatory and formulation specifics, including the iron salt identity, dissolution profile targets, and excipient system.

What affects batch release and quality agreements for iron/folate combos?

Not determinable.

What is the Orange Book status of CHABELINA FE (if approved in the US)?

Answer: Not determinable from the prompt. Orange Book status requires the exact US product identifier (application number, strength, dosage form, and active ingredient mapping).

Do CHABELINA FE suppliers change after generic or private-label entry?

Answer: Not determinable. Private-labeling and relabeling can switch contract manufacturers while keeping the same brand name in some markets.

Which countries have validated supplier networks for CHABELINA FE?

Answer: Not determinable. Supplier networks are jurisdiction-specific and depend on the drug registry and distribution chain for that country.

How strong is the supply-risk profile for CHABELINA FE based on API sourcing?

Answer: Not determinable. Risk depends on the specific APIs used, their manufacturers, availability of alternate iron/falter excipient supply, and any qualified vendor list (QVL) constraints.

How does CHABELINA FE compare with other iron + folate brands in supply chain structure?

Answer: Not determinable without knowing the formulation and market authorization holder for CHABELINA FE.

Key Takeaways

  • No non-speculative supplier list for “CHABELINA FE” can be produced from the provided input.
  • Supplier identification requires confirmed product mapping (country listing and marketing authorization/manufacturer details or a verified label/NDC/registration entry).

FAQs

  1. What iron salt is used in CHABELINA FE?
    Not determinable from the prompt.

  2. Who manufactures CHABELINA FE in [country]?
    Not determinable from the prompt because the country listing is not specified.

  3. Is CHABELINA FE FDA-approved or listed in the Orange Book?
    Not determinable from the prompt.

  4. Which companies supply ferrous sulfate vs ferrous fumarate for combination iron/folate tablets?
    Not determinable for CHABELINA FE specifically.

  5. How can I identify CHABELINA FE contract manufacturing sources?
    Not determinable from the prompt without product label/registry mapping.

References

No sources cited because no verifiable CHABELINA FE listing or product identifier was provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.